Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

7th Eurasian Hematology Oncology Summit
R

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / Consolidation Dasatinib + Blinatumomab the Optimal Solution?

By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
14 views
December 15, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
COVID-19
19:08

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / …

7th Eurasian Hematology Oncology Summit

R. Foa

14 views
17:27

How SARS-CoV-2 Affects Cancer Patients: Epidemiology, Behavior, Symp…

7th Eurasian Hematology Oncology Summit

R. Chemaly

6 views
16:36

CLL Management During the COVID-19 Pandemic: New Strategies and Cons…

7th Eurasian Hematology Oncology Summit

R. Foa

22 views